| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0089 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |